A phase 2, multicenter, double-blind, randomized, vehicle-controlled clinical study to compare the safety and efficacy of a halobetasol propionate 0.01% lotion and halobetasol propionate 0.05% cream in the treatment of plaque psoriasis
2018 ◽
Vol 30
(4)
◽
pp. 333-339
◽
Keyword(s):
Phase 2
◽